Development Level

Tdark 367 | 6,588
Tbio 26 | 11,445
Tchem 14 | 1,598
Tclin 7 | 613

Collection

RFA-RM-18-021 3 | 328
Kinase: IDG Consortium (Target... 2 | 125
Ion Channel: IDG Consortium (T... 1 | 99

IMPC Phenotype

preweaning lethality, incomple... 6 | 499
decreased total body fat amoun... 3 | 207
increased circulating alkaline... 3 | 122
abnormal sleep behavior 2 | 70
enlarged heart 2 | 210
enlarged spleen 2 | 41
increased circulating HDL chol... 2 | 80
increased circulating choleste... 2 | 66
increased circulating sodium l... 2 | 71
increased startle reflex 2 | 112
thrombocytopenia 2 | 56
abnormal behavior 1 | 298
abnormal bone structure 1 | 187
abnormal duodenum morphology 1 | 4
abnormal retinal blood vessel ... 1 | 26
abnormal skin morphology 1 | 50
cardiovascular system phenotyp... 1 | 36
decreased body length 1 | 101
decreased bone mineral content 1 | 151
decreased bone mineral density 1 | 126
decreased lean body mass 1 | 135
decreased mean corpuscular hem... 1 | 31
decreased prepulse inhibition 1 | 82
decreased vertical activity 1 | 208
enlarged thymus 1 | 5
enlarged uterus 1 | 11
hyperactivity 1 | 148
impaired pupillary reflex 1 | 26
increased circulating phosphat... 1 | 26
increased mean corpuscular hem... 1 | 96
increased total body fat amoun... 1 | 134
mydriasis 1 | 6
small kidney 1 | 16
small superior vagus ganglion 1 | 74

Disease

Carcinoma 343 | 11,493
diabetes mellitus 67 | 1,728
medulloblastoma, large-cell 44 | 6,241
osteosarcoma 39 | 7,950
ovarian cancer 34 | 8,520
adult high grade glioma 29 | 3,801
glioblastoma 25 | 5,792
lung cancer 25 | 4,740
atypical teratoid / rhabdoid tumor 24 | 5,112
ependymoma 24 | 4,679
psoriasis 24 | 6,694
Kidney cancer 17 | 2,613
primitive neuroectodermal tumor 17 | 3,035
group 3 medulloblastoma 16 | 4,104
lung carcinoma 16 | 2,843
Breast cancer 15 | 3,578
oligodendroglioma 15 | 2,850
astrocytic glioma 14 | 2,597
Astrocytoma, Pilocytic 13 | 3,081
Hemolytic anemia 13 | 77
lung adenocarcinoma 12 | 2,716
malignant mesothelioma 12 | 3,232
Pick disease 10 | 1,894
colon cancer 10 | 1,478
intraductal papillary-mucinous neoplasm (IPMN) 10 | 3,291
non-small cell lung cancer 10 | 2,890
pituitary cancer 10 | 1,972
subependymal giant cell astrocytoma 10 | 2,287
Rheumatoid arthritis 9 | 1,191
Schizophrenia 9 | 1,160
cystic fibrosis 9 | 1,696
non primary Sjogren syndrome sicca 9 | 891
group 4 medulloblastoma 8 | 1,855
intraductal papillary-mucinous adenoma (IPMA) 8 | 2,955
intraductal papillary-mucinous carcinoma (IPMC) 8 | 2,989
invasive ductal carcinoma 8 | 2,951
tuberculosis 8 | 2,010
Depressive disorder 7 | 409
Hypertension 7 | 396
breast carcinoma 7 | 1,638
ulcerative colitis 7 | 1,819
Bipolar Disorder 6 | 666
pancreatic cancer 6 | 2,398
Acquired metabolic disease 5 | 336
Cancer 5 | 2,499
Cataract 21 multiple types 5 | 6
Cataract 3 multiple types 5 | 10
Cataract 37 5 | 5
Cataract 4 multiple types 5 | 14
Cataract 7 5 | 32
Melanoma 5 | 711
Mental Depression 5 | 333
Skin cancer 5 | 469
ductal carcinoma in situ 5 | 1,745
interstitial cystitis 5 | 2,312
Anorexia nervosa 4 | 80
Atrial Fibrillation 4 | 124
Autosomal recessive predisposition 4 | 1,442
Chronic heart failure 4 | 46
Epilepsy 4 | 792
Heart disease 4 | 306
Hypertensive disease 4 | 292
Major Depressive Disorder 4 | 301
Malaria 4 | 160
Myocardial Perfusion Imaging Adjunct 4 | 25
Platelet Aggregation Inhibition 4 | 22
Prevention of Cerebral Thrombosis 4 | 29
Retinitis Pigmentosa 4 | 226
Sickle Cell Anemia 4 | 53
Thalassemia 4 | 53
acute quadriplegic myopathy 4 | 1,158
adrenocortical carcinoma 4 | 1,428
medulloblastoma 4 | 720
non-small cell lung carcinoma 4 | 317
Abnormality of retinal pigmentation 3 | 111
Alzheimer's disease 3 | 658
Blind Vision 3 | 111
Blindness 3 | 88
Blindness, Legal 3 | 110
Brain Ischemia 3 | 110
Cerebrovascular disease 3 | 238
Crohn's disease 3 | 321
Difficulties with night vision 3 | 87
Duchenne muscular dystrophy 3 | 601
Liver Cirrhosis, Experimental 3 | 769
Night Blindness 3 | 101
Photodysphoria 3 | 121
Photophobia 3 | 121
Retinal pigment epithelial abnormality 3 | 111
Schnyder Corneal Dystrophy 3 | 23
Seizures 3 | 596
Sporotrichosis 3 | 10
Toxic encephalopathy 3 | 141
Ventricular arrhythmia 3 | 27
active Crohn's disease 3 | 922
active ulcerative colitis 3 | 764
nasopharyngeal carcinoma 3 | 1,058
pediatric high grade glioma 3 | 1,064
primary pancreatic ductal adenocarcinoma 3 | 1,109
substance-related disorder 3 | 162

Tissue

Endocrine System 145 | 18,159
Female tissues 81 | 17,400
Male tissues 81 | 17,142
Blood and immune system 76 | 16,909
Digestive Tract 64 | 17,369
Nervous System 64 | 16,725
Skin and soft tissues 60 | 17,230
Urinary Tract 60 | 16,678
Liver and Pancreas 55 | 16,750
Respiratory system 50 | 16,393
Cardiovascular System 42 | 15,192

Target Family

oGPCR 373 | 421
Non-IDG 15 | 12,091
Kinase 12 | 634
Enzyme 5 | 4,145
Ion Channel 5 | 344
Transporter 4 | 473

KEGG Pathway

Olfactory transduction 414 | 414
Metabolic pathways 1,263 | 1,263
Pathways in cancer 530 | 530
Human papillomavirus infection 388 | 388
PI3K-Akt signaling pathway 349 | 349
HTLV-I infection 336 | 336
Endocytosis 310 | 310
MAPK signaling pathway 295 | 295
Epstein-Barr virus infection 280 | 280
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 267 | 267
Herpes simplex infection 262 | 262
Kaposi's sarcoma-associated he... 252 | 252
Viral carcinogenesis 251 | 251
Thermogenesis 232 | 232
Ras signaling pathway 230 | 230
Phagosome 229 | 229
Cellular senescence 228 | 228
Cell adhesion molecules (CAMs) 225 | 225
Rap1 signaling pathway 209 | 209
Regulation of actin cytoskelet... 207 | 207
cAMP signaling pathway 201 | 201
Focal adhesion 198 | 198
Proteoglycans in cancer 198 | 198
Natural killer cell mediated c... 197 | 197
Huntington's disease 194 | 194
Tuberculosis 189 | 189
Calcium signaling pathway 183 | 183
Chemokine signaling pathway 183 | 183
Influenza A 182 | 182
Axon guidance 174 | 174
Purine metabolism 172 | 172
Alzheimer's disease 171 | 171
Transcriptional misregulation ... 171 | 171
Tight junction 169 | 169
Hepatocellular carcinoma 168 | 168
NOD-like receptor signaling pa... 166 | 166
Protein processing in endoplas... 164 | 164
RNA transport 163 | 163
cGMP-PKG signaling pathway 162 | 162
Jak-STAT signaling pathway 161 | 161
Cushing's syndrome 158 | 158
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
Necroptosis 154 | 154
Oxytocin signaling pathway 154 | 154
MicroRNAs in cancer 150 | 150
mTOR signaling pathway 150 | 150
Non-alcoholic fatty liver dise... 149 | 149
Gastric cancer 148 | 148
Retrograde endocannabinoid sig... 148 | 148
Adrenergic signaling in cardio... 147 | 147
Alcoholism 147 | 147
Breast cancer 147 | 147
Phospholipase D signaling path... 147 | 147
Wnt signaling pathway 145 | 145
Hepatitis B 143 | 143
Parkinson's disease 142 | 142
Estrogen signaling pathway 139 | 139
Apoptosis 138 | 138
Fluid shear stress and atheros... 138 | 138
Signaling pathways regulating ... 138 | 138
Insulin signaling pathway 137 | 137
Ubiquitin mediated proteolysis 137 | 137
Viral myocarditis 137 | 137
Apelin signaling pathway 136 | 136
Dopaminergic synapse 135 | 135
Ribosome 134 | 134
Measles 133 | 133
Oxidative phosphorylation 133 | 133
Relaxin signaling pathway 133 | 133
Spliceosome 132 | 132
Autoimmune thyroid disease 130 | 130
FoxO signaling pathway 130 | 130
Hepatitis C 130 | 130
Autophagy - animal 128 | 128
Osteoclast differentiation 127 | 127
Cell cycle 125 | 125
Platelet activation 125 | 125
Toxoplasmosis 125 | 125
Lysosome 123 | 123
Vascular smooth muscle contrac... 123 | 123
Type I diabetes mellitus 122 | 122
Oocyte meiosis 121 | 121
AMPK signaling pathway 120 | 120
Graft-versus-host disease 120 | 120
Neurotrophin signaling pathway 119 | 119
Th17 cell differentiation 119 | 119
Sphingolipid signaling pathway 118 | 118
Allograft rejection 116 | 116
Carbon metabolism 116 | 116
Glutamatergic synapse 116 | 116
Thyroid hormone signaling path... 116 | 116
Serotonergic synapse 114 | 114
Leukocyte transendothelial mig... 112 | 112
Cholinergic synapse 111 | 111
Hematopoietic cell lineage 108 | 108
Systemic lupus erythematosus 108 | 108
TNF signaling pathway 108 | 108
Insulin resistance 107 | 107

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Olfactory receptor 51B2 OR51B2 Tdark oGPCR 0.12 0.65 26
Olfactory receptor 51B4 OR51B4 Tdark oGPCR 0.05 1.19 4
Olfactory receptor 5B2 OR5B2 Tdark oGPCR 0.00000 1
Olfactory receptor 2A7 OR2A7 Tdark oGPCR 0.00000 23
Olfactory receptor 2A14 OR2A14 Tdark oGPCR 0.85 0.13 6
Olfactory receptor 52A1 OR52A1 Tdark oGPCR 0.18 1.00 92
Olfactory receptor 6C68 OR6C68 Tdark oGPCR 0.00000 49
Olfactory receptor 2M4 OR2M4 Tdark oGPCR 0.95 0.18 19
Olfactory receptor 2M2 OR2M2 Tdark oGPCR 0.00000 61
Olfactory receptor 2A5 OR2A5 Tdark oGPCR 0.60 0.17 65